Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ribas

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoproteinL H Butterfield, W S Meng, A Koh, et al.
Cancer Gene Therapy|December 23, 1999
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cellsA Ribas, L H Butterfield, B Hu, et al.
Tumori|November 1, 1996
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI)A Ribas, J Bellmunt, J Albanell, et al.
The Journal of Small Animal Practice|January 27, 2019
Canine sterile steroid-responsive lymphadenitis in 49 dogsA Ribas Latre, A McPartland, D Cain, et al.
Journal of Evolutionary Biology|July 16, 2008
Multiple parasites mediate balancing selection at two MHC class II genes in the fossorial water vole: insights from multivariate analyses and population geneticsC Tollenaere, J Bryja, M Galan, et al.
Cell Death & Disease|October 17, 2014
Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug developmentS Senese, Y C Lo, D Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2017
Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM studyB Dréno, A Ribas, J Larkin, et al.
AIDS Research and Treatment|June 12, 2015
Relationships between Serum Levels of Atazanavir and Renal Toxicity or LithiasisC I Marinescu, M Leyes, M A Ribas, et al.
American Journal of Clinical Oncology|August 1, 1996
M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladderJ Bellmunt, A Ribas, J Albanell, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoproteinL H Butterfield, W S Meng, A Koh, et al.
Cancer Gene Therapy|December 23, 1999
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cellsA Ribas, L H Butterfield, B Hu, et al.
Tumori|November 1, 1996
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI)A Ribas, J Bellmunt, J Albanell, et al.
The Journal of Small Animal Practice|January 27, 2019
Canine sterile steroid-responsive lymphadenitis in 49 dogsA Ribas Latre, A McPartland, D Cain, et al.
Journal of Evolutionary Biology|July 16, 2008
Multiple parasites mediate balancing selection at two MHC class II genes in the fossorial water vole: insights from multivariate analyses and population geneticsC Tollenaere, J Bryja, M Galan, et al.
Cell Death & Disease|October 17, 2014
Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug developmentS Senese, Y C Lo, D Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2017
Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM studyB Dréno, A Ribas, J Larkin, et al.
AIDS Research and Treatment|June 12, 2015
Relationships between Serum Levels of Atazanavir and Renal Toxicity or LithiasisC I Marinescu, M Leyes, M A Ribas, et al.
American Journal of Clinical Oncology|August 1, 1996
M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladderJ Bellmunt, A Ribas, J Albanell, et al.
Pageof 14